Skip to content
★ Sign in to follow
AP

Adam Power

Executive
Surgical Innovations Group plc
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€2,255
▼ Sales (0 ops.)
—

Latest filing published 09 Jul 2021 for Surgical Innovations Group plc, €131k.

Filing timeline

BuySale
Adam Power

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
100%
Median T+90
+3.8%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Adam Power: trading record in brief

Adam Power is a declared insider of Surgical Innovations Group plc, with filings sourced from RNS (LSE). The record holds 3 filings, for trades running from 27 September 2017 to 7 July 2021.

Every open-market trade on record is a purchase: 2 purchases worth €2,255, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The record was last updated on 9 July 2021 with a transaction (€131k) in Surgical Innovations Group plc. The last insider purchase was made public on 15 November 2017, 3,281 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 5 days. The regulation allows three business days to notify a trade (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Adam Power

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    Group Development DirectorExecutivesSurgical Innovations Group plc
    111,719 GBP19FCA-NSM
    3,437,500 shares@ £0.032598.3% of flowOff-market TransactionISIN GB0004016704FCA-NSM:4040353
  • ▲
    Group Development Director, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    994 GBP31FCA-NSM
    29,690 shares@ £0.033549.7% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20171115114735_13432637_20200330131534524_12690-1
    Canonical exit: 8 Feb 2018 (T+90)
  • ▲
    Group Development Director, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    994 GBP16FCA-NSM
    27,612 shares@ £0.03650.3% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20171115114735_13432637_20200330131534524_12690-0
    Canonical exit: 26 Dec 2017 (T+90)

3 of 3 declarations